Bodhi Tree Biotechnology Inc. (BDTB)

Bodhi Tree Biotechnology Financials Overview

Financials in millions USD. Fiscal year is October - September.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024
Revenue Revenue Growth	0.04	0.02	0.04
Revenue Growth	15.63%	-59.52%	-
Gross Profit Gross Profit Growth	0.04	0.02	0.04
Operating Income Operating Income Growth	-0.11	-0.15	-0.07
Net Income Net Income Growth	-0.12	-0.15	-0.07
Earnings Per Share EPS Growth	-0.00	-0.01	-
EPS Growth	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024
Net Cash (Debt) Net Cash Growth	0	0.11	0.26
Net Cash Growth	-96.67%	-57.85%	-
Net Cash Per Share Net Cash Per Share Growth	0.00	0.00	0.02
Cash & Investments Cash & Investments Growth	0	0.11	0.26

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024
Operating Cash Flow Operating Cash Flow Growth	-0.12	-0.15	-0.09
Free Cash Flow Free Cash Flow Growth	-0.12	-0.15	-0.09
Free Cash Flow Growth	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-310.18%	-868.34%	-177.01%
Pretax Margin	-310.17%	-868.33%	-177.01%
Profit Margin	-313.58%	-880.39%	-177.01%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 24, 2026

Data Sources Report a data error